American Portfolios Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
American Portfolios Advisors's BIIB Position: Q3 2022 in Review
American Portfolios Advisors reduced its Biogen (BIIB) stake by 22% in Q3 2022, selling an estimated $534K and leaving 8,744 shares worth $2.33M. The position accounts for 0.1% of the portfolio, ranked #208.
American Portfolios Advisors first reported a position in BIIB in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.58M in Q2 2021. 986 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.
- American Portfolios Advisors held 8,744 shares of Biogen worth $2.33M as of Q3 2022.
- American Portfolios Advisors sold 2,513 Biogen shares in Q3 2022, an estimated $534K.
- Biogen made up 0.1% of American Portfolios Advisors's portfolio in Q3 2022, its #208 holding.
- American Portfolios Advisors first reported a position in Biogen in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's Biogen position peaked at $3.58M in Q2 2021.
- 986 funds tracked by Wall St. Rank held Biogen as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.